chrX-154348765-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001110556.2(FLNA):c.*84A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.129 in 982,339 control chromosomes in the GnomAD database, including 6,645 homozygotes. There are 36,799 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.16 ( 1311 hom., 5235 hem., cov: 24)
Exomes 𝑓: 0.13 ( 5334 hom. 31564 hem. )
Consequence
FLNA
NM_001110556.2 3_prime_UTR
NM_001110556.2 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.718
Publications
1 publications found
Genes affected
FLNA (HGNC:3754): (filamin A) The protein encoded by this gene is an actin-binding protein that crosslinks actin filaments and links actin filaments to membrane glycoproteins. The encoded protein is involved in remodeling the cytoskeleton to effect changes in cell shape and migration. This protein interacts with integrins, transmembrane receptor complexes, and second messengers. Defects in this gene are a cause of several syndromes, including periventricular nodular heterotopias (PVNH1, PVNH4), otopalatodigital syndromes (OPD1, OPD2), frontometaphyseal dysplasia (FMD), Melnick-Needles syndrome (MNS), and X-linked congenital idiopathic intestinal pseudoobstruction (CIIPX). Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2009]
FLNA Gene-Disease associations (from GenCC):
- periventricular nodular heterotopiaInheritance: AD, XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- frontometaphyseal dysplasia 1Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
- genetic developmental and epileptic encephalopathyInheritance: XL Classification: DEFINITIVE Submitted by: G2P
- heterotopia, periventricular, X-linked dominantInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Illumina
- intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linkedInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- Melnick-Needles syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- otopalatodigital syndrome type 2Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- terminal osseous dysplasia-pigmentary defects syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- cardiac valvular dysplasia, X-linkedInheritance: XL Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- frontometaphyseal dysplasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- congenital short bowel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- otopalatodigital syndrome type 1Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- X-linked Ehlers-Danlos syndromeInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- familial thoracic aortic aneurysm and aortic dissectionInheritance: XL Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant X-154348765-T-G is Benign according to our data. Variant chrX-154348765-T-G is described in ClinVar as [Benign]. Clinvar id is 1258029.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.274 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.160 AC: 17778AN: 110890Hom.: 1306 Cov.: 24 show subpopulations
GnomAD3 genomes
AF:
AC:
17778
AN:
110890
Hom.:
Cov.:
24
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.126 AC: 109371AN: 871402Hom.: 5334 Cov.: 14 AF XY: 0.131 AC XY: 31564AN XY: 240428 show subpopulations
GnomAD4 exome
AF:
AC:
109371
AN:
871402
Hom.:
Cov.:
14
AF XY:
AC XY:
31564
AN XY:
240428
show subpopulations
African (AFR)
AF:
AC:
6104
AN:
21208
American (AMR)
AF:
AC:
4974
AN:
24260
Ashkenazi Jewish (ASJ)
AF:
AC:
853
AN:
14316
East Asian (EAS)
AF:
AC:
1903
AN:
26960
South Asian (SAS)
AF:
AC:
7413
AN:
41338
European-Finnish (FIN)
AF:
AC:
5093
AN:
33098
Middle Eastern (MID)
AF:
AC:
202
AN:
2915
European-Non Finnish (NFE)
AF:
AC:
77847
AN:
669455
Other (OTH)
AF:
AC:
4982
AN:
37852
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
3394
6788
10181
13575
16969
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.161 AC: 17819AN: 110937Hom.: 1311 Cov.: 24 AF XY: 0.157 AC XY: 5235AN XY: 33299 show subpopulations
GnomAD4 genome
AF:
AC:
17819
AN:
110937
Hom.:
Cov.:
24
AF XY:
AC XY:
5235
AN XY:
33299
show subpopulations
African (AFR)
AF:
AC:
8494
AN:
30414
American (AMR)
AF:
AC:
1757
AN:
10655
Ashkenazi Jewish (ASJ)
AF:
AC:
142
AN:
2631
East Asian (EAS)
AF:
AC:
196
AN:
3481
South Asian (SAS)
AF:
AC:
454
AN:
2687
European-Finnish (FIN)
AF:
AC:
841
AN:
5995
Middle Eastern (MID)
AF:
AC:
11
AN:
212
European-Non Finnish (NFE)
AF:
AC:
5689
AN:
52669
Other (OTH)
AF:
AC:
233
AN:
1514
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
512
1024
1535
2047
2559
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 28, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.